Counselors in Newport, DE Accepting Medicare
6 Counselors found. Showing 1 - 6
 Ms. Frann Salley Anderson, LCSW Counselor - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 240 N James St, Suite 111, Newport, DE 19804 Phone: 302-407-1645 Fax: 302-295-6289 |
Dr. Donna J. Tuites, LPCMH Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 240 N James St, Suite 111, Newport, DE 19804 Phone: 302-407-1645 |
Miss Carrie S Joseph, LPCMH Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 242 N James St, Suite 102, Newport, DE 19804 Phone: 302-507-1822 |
Ms. Vasanthy C. Chennat, LPCMH Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 240 N James St, Suite 111, Newport, DE 19804 Phone: 302-407-1645 Fax: 302-295-6289 |
Jessica Sandra Sinarski, LPCMH Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 240 N James St, Suite 200, Newport, DE 19804 Phone: 302-633-0301 Fax: 302-633-0331 |
Karen J Shinkle, LPCMH Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 240 N James St, Suite # 104-106, Newport, DE 19804 Phone: 302-633-0301 |
News Archive
CodeSmart enters into agreements with Mennonite Hospital System in Puerto Rico
CodeSmart Holdings, Inc. (OTCQB: ITEN), with its subsidiary, The CODESMART™ Group, Inc. (collectively, "CODESMART"), a premier ICD-10 education and solutions group that offers CODESMART™ UNIVERSITY, its on-line education solution and customizable training solutions, announced today that it has entered into agreements with Mennonite Hospital System and San Lucas Hospital in Puerto Rico.
FDA ODAC recommends approval of Seattle Genetics' ADCETRIS for Hodgkin lymphoma after ASCT
Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
Study investigates barriers faced by high schools when implementing state concussion laws
All 50 U.S. states enacted concussion laws between 2009-2014 to mitigate the consequences of concussion. While details of the laws vary from state to state, all state laws address three main factors: concussion education; removal from play after suspected concussion; and return-to-play requirements.
FDA grants accelerated approval for Allos Therapeutics' FOLOTYN
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Suicide risk drops with antidepressants
According to a new study the risk of suicide is not increased when adults start using antidepressants, and does in fact drop almost as soon as medication is begun.
› Verified 1 days ago